AR095276A1 - Péptidos para el rejuvenecimiento de la piel y métodos para utilizarlos - Google Patents
Péptidos para el rejuvenecimiento de la piel y métodos para utilizarlosInfo
- Publication number
- AR095276A1 AR095276A1 ARP140100889A ARP140100889A AR095276A1 AR 095276 A1 AR095276 A1 AR 095276A1 AR P140100889 A ARP140100889 A AR P140100889A AR P140100889 A ARP140100889 A AR P140100889A AR 095276 A1 AR095276 A1 AR 095276A1
- Authority
- AR
- Argentina
- Prior art keywords
- collagen
- composition
- compositions
- carnosine
- acid derivative
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000003716 rejuvenation Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 12
- 108010087806 Carnosine Proteins 0.000 abstract 5
- 102000008186 Collagen Human genes 0.000 abstract 5
- 108010035532 Collagen Proteins 0.000 abstract 5
- 229920001436 collagen Polymers 0.000 abstract 5
- 239000002253 acid Substances 0.000 abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 abstract 3
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 abstract 3
- 229940044199 carnosine Drugs 0.000 abstract 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 210000002744 extracellular matrix Anatomy 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
- CUVSTAMIHSSVKL-UWVGGRQHSA-N (4s)-4-[(2-aminoacetyl)amino]-5-[[(2s)-6-amino-1-(carboxymethylamino)-1-oxohexan-2-yl]amino]-5-oxopentanoic acid Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CN CUVSTAMIHSSVKL-UWVGGRQHSA-N 0.000 abstract 1
- 102100035337 Bone marrow proteoglycan Human genes 0.000 abstract 1
- 101710134771 Bone marrow proteoglycan Proteins 0.000 abstract 1
- 102000012422 Collagen Type I Human genes 0.000 abstract 1
- 108010022452 Collagen Type I Proteins 0.000 abstract 1
- 102000016942 Elastin Human genes 0.000 abstract 1
- 108010014258 Elastin Proteins 0.000 abstract 1
- 229920002971 Heparan sulfate Polymers 0.000 abstract 1
- -1 Octanoyl Carnosine Chemical compound 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 229920002549 elastin Polymers 0.000 abstract 1
- 102000013370 fibrillin Human genes 0.000 abstract 1
- 108060002895 fibrillin Proteins 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 238000007920 subcutaneous administration Methods 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composiciones para estimular la formación de uno o más componentes de matriz extracelular que contienen un derivado lipoaminoácido del dipéptido carnosina. Composiciones que contienen N-Octanoil carnosina en combinación con los tripéptidos y/o tetrapéptidos seleccionados así como también, composiciones farmacéuticas y/o cosméticas que contienen dichas composiciones. Métodos para utilizar las composiciones y composiciones de la presente para tratar, aliviar y/o mejorar un síntoma, condición, trastorno o enfermedad de la piel o mucosa donde el síntoma, condición, trastorno o enfermedad está asociado con cambios en los componentes de la matriz extracelular. Reivindicación 2: La composición de la reivindicación 1, caracterizada porque el derivado lipoaminoácido del dipéptido carnosina es N-Octanoil Carnosina. Reivindicación 3: La composición de la reivindicación 2, caracterizada porque la composición además comprende uno o más vehículos o excipientes adecuados para la administración tópica o subcutánea. Reivindicación 4: La composición de la reivindicación 3, caracterizada porque el, uno o más componentes de matriz extracelular se seleccionan del grupo formado por colágeno I, colágeno III, colágeno V, colágeno VI, colágeno VII, colágeno XVI, elastina, laminina, ácido hialurónico, fibrilina, sulfato de heparán proteoglicano 2, y combinaciones de los mismos. Reivindicación 9: La composición de la reivindicación 8, caracterizada porque la composición comprende Octanoil Carnosina, el derivado lipoaminoácido del tripéptido GHK (N-Palmitoil-GHK), y el tetrapéptido GEKG (Nº ID DE SEC: 1).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361779601P | 2013-03-13 | 2013-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR095276A1 true AR095276A1 (es) | 2015-09-30 |
Family
ID=51263427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140100889A AR095276A1 (es) | 2013-03-13 | 2014-03-12 | Péptidos para el rejuvenecimiento de la piel y métodos para utilizarlos |
Country Status (14)
Country | Link |
---|---|
US (3) | US9375398B2 (es) |
EP (1) | EP2970382B1 (es) |
JP (1) | JP6326601B2 (es) |
KR (1) | KR102276326B1 (es) |
CN (1) | CN105189531B (es) |
AR (1) | AR095276A1 (es) |
AU (1) | AU2014229557B2 (es) |
CA (1) | CA2902938C (es) |
HK (1) | HK1212363A1 (es) |
MX (1) | MX360649B (es) |
RU (1) | RU2666533C2 (es) |
SG (1) | SG11201506069RA (es) |
TW (1) | TWI652066B (es) |
WO (1) | WO2014140890A2 (es) |
Families Citing this family (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX360649B (es) | 2013-03-13 | 2018-11-12 | Anteis Sa | Péptidos para el rejuvenecimiento de la piel y métodos de uso de los mismos. |
WO2015069843A2 (en) | 2013-11-08 | 2015-05-14 | Hollister Incorporated | Oleophilic lubricated catheters |
BR112016013522B1 (pt) | 2013-12-20 | 2020-11-10 | Colgate-Palmolive Company | produto para higiene oral e branqueamento dos dentes com partículas de sílica em revestimento de núcleo |
EP3084037B1 (en) | 2013-12-20 | 2020-10-21 | Colgate-Palmolive Company | Core shell silica particles and uses thereof as an anti-bacterial agent |
BR112017000937B1 (pt) * | 2014-07-31 | 2022-01-25 | Kimberly-Clark Worldwide, Inc. | Composição antiaderente e lenço |
CA2972015A1 (en) * | 2014-12-23 | 2016-06-30 | Avon Products, Inc. | Peptides and their use in the treatment of skin |
JP2016150919A (ja) * | 2015-02-18 | 2016-08-22 | ピアス株式会社 | 塗布用化粧品組成物 |
MX2017011771A (es) | 2015-04-01 | 2017-12-04 | Kimberly Clark Co | Sustrato fibroso para la captura de bacterias gramnegativas. |
ITUB20152695A1 (it) | 2015-07-31 | 2017-01-31 | Metis Healthcare S R L | Composizione per l'aumento delle secrezioni umorali |
ES2907686T3 (es) | 2015-11-03 | 2022-04-26 | Zoetis Services Llc | Compuestos poliméricos sol-gel y sus usos |
US10729628B2 (en) | 2015-12-24 | 2020-08-04 | Conopco, Inc. | Tyrosinase inhibitors |
KR101843065B1 (ko) * | 2016-01-06 | 2018-03-28 | 바이오스펙트럼 주식회사 | 카노신, 대두 펩타이드 및 천심련 추출물을 포함하는 항노화용 조성물 |
CN106975523A (zh) * | 2016-01-19 | 2017-07-25 | 广州绿恒环保科技有限公司 | 一种新型的具有渗透分解功能光触媒液体 |
GB201601136D0 (en) | 2016-01-21 | 2016-03-09 | Mörgelin Matthias And Abdillahi Suado M | Novel polypeptides and medical uses thereof |
US12037497B2 (en) | 2016-01-28 | 2024-07-16 | Kimberly-Clark Worldwide, Inc. | Anti-adherent composition against DNA viruses and method of inhibiting the adherence of DNA viruses to a surface |
US20170216584A1 (en) * | 2016-01-29 | 2017-08-03 | Insung Information Co., Ltd. | Sheet mask for iontophoresis and mask assembly using the same |
BR112018015897B1 (pt) | 2016-02-04 | 2022-03-03 | Alastin Skincare, Inc | Composição tópica anidra para promover a reparação da pele, composições tópicas para promover a restauração da pele, composição tópica para aliviar contusões causadas por um procedimento cosmético e uso das mesmas |
US10988731B2 (en) * | 2016-04-29 | 2021-04-27 | Hope Biosciences, Llc | Formulation for storage, transportation, and delivery of protein rich conditioned medium |
JP6489487B2 (ja) * | 2017-01-20 | 2019-03-27 | 富比積生物科技股▲分▼有限公司 | テトラペプチド−3 gekgまたはペンタペプチド−3 gekgfにより変形性関節症を治療するための新規用途 |
ES2889579T3 (es) | 2017-02-17 | 2022-01-12 | Imertech Sas | Uso de un mineral particulado para reducir la contaminación |
AU2018243658A1 (en) * | 2017-03-30 | 2019-11-07 | Escape Therapeutics, Inc. | Decapeptide-12 modulation of sirtuin gene expression in epidermal keratinocyte progenitors |
KR101956572B1 (ko) * | 2017-04-05 | 2019-06-24 | 에이앤펩주식회사 | 기능성 펩타이드와 콜라겐 발효물을 포함하는 주름 개선용 조성물 |
CN107308101B (zh) * | 2017-06-13 | 2020-06-19 | 湖南御家化妆品制造有限公司 | 皮肤紧致组合物及其应用 |
JP6901801B2 (ja) * | 2017-06-14 | 2021-07-14 | バイオソリューション カンパニー・リミテッドBio Solution Co Ltd | 物質pを含むしわの改善または抗炎症化粧料組成物 |
US10258556B2 (en) * | 2017-06-19 | 2019-04-16 | Yu-Chun Liu | Anti-aging peptide, its composition and method of using the same |
BR112020002222A2 (pt) * | 2017-08-03 | 2020-07-28 | ALASTIN Skincare, Inc. | composições e métodos para melhora da flacidez da pele e do contorno corporal |
IT201700102009A1 (it) * | 2017-09-12 | 2019-03-12 | Promoitalia Group Spa | Composizione rigenerante e ad azione levigante per il trattamento degli inestetismi della pelle e relativo procedimento di preparazione |
AU2018334419A1 (en) * | 2017-09-18 | 2020-03-05 | Incube Labs Llc | Iontophoretic systems, kits and methods for transdermal delivery of cosmetic agents |
CN107857799B (zh) * | 2017-11-20 | 2021-06-04 | 陕西慧康生物科技有限责任公司 | 一种四肽-21的液相合成方法 |
MX2020006001A (es) | 2017-12-12 | 2022-04-12 | Colgate Palmolive Co | Composicion para el cuidado personal. |
CN108218956A (zh) * | 2018-02-23 | 2018-06-29 | 广州同隽医药科技有限公司 | 一种棕榈酰三肽-1的液相合成方法 |
FR3080532A1 (fr) * | 2018-04-26 | 2019-11-01 | Codexial Dermatologie | Preparation magistrale dermatologique |
CN112088010A (zh) * | 2018-05-04 | 2020-12-15 | 宝洁公司 | 用于治疗阴道干燥的组合物和方法 |
CN108744024A (zh) * | 2018-05-24 | 2018-11-06 | 海南芬森医疗器械有限公司 | 一种复配防疤痕液剂生物敷料及其制备方法 |
CN108715833B (zh) * | 2018-06-01 | 2021-09-14 | 天晴干细胞股份有限公司 | 一种负载血小板裂解液的微球制备方法 |
CN108888799A (zh) * | 2018-06-25 | 2018-11-27 | 东莞市联洲知识产权运营管理有限公司 | 一种具有驱虫性能的增强型复合纤维素医用敷料及其制备方法 |
KR101924894B1 (ko) * | 2018-07-25 | 2018-12-04 | 베네브바이오랩 주식회사 | 소음순 피부 치료용 피부연고 |
US11103455B2 (en) | 2018-08-02 | 2021-08-31 | ALASTIN Skincare, Inc. | Liposomal compositions and methods of use |
WO2020041695A1 (en) * | 2018-08-23 | 2020-02-27 | The General Hospital Corporation | Multifunctional skin patch |
KR101965607B1 (ko) * | 2018-08-27 | 2019-04-04 | (주)씨앤케이코스메디칼 | 불연속상 하이드로겔 및 옥수수 전분을 결합제로 포함하는 외력붕해성 고형 클렌저 및 이의 제조 방법 |
RU2681310C1 (ru) * | 2018-09-05 | 2019-03-06 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ первичной хирургической обработки инфицированных ран кожи и мягких тканей с использованием пептида Gly-His-Lys-D-Ala |
RU2681216C1 (ru) * | 2018-09-05 | 2019-03-05 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ стимуляции регенерации инфицированных ран кожи и мягких тканей с применением пептида Gly-His-Lys-D-Ala |
US10881882B1 (en) * | 2018-12-21 | 2021-01-05 | Btl Medical Technologies S.R.O. | Methods and devices for tissue treatment |
GB201900728D0 (en) * | 2019-01-18 | 2019-03-06 | Univ Birmingham | Drug delivery system |
CZ308845B6 (cs) * | 2019-01-21 | 2021-07-07 | Globetech Innovation S.R.O | Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran |
KR102203356B1 (ko) * | 2019-01-28 | 2021-01-18 | (주)더마펌 | 피부 노화방지 및 주름개선용 펩타이드 및 이를 포함하는 조성물 |
US20200237626A1 (en) * | 2019-01-28 | 2020-07-30 | Jamrm, Llc | Anti-Aging Corrective and Protective Formulation and Methods |
EP3930740A4 (en) * | 2019-02-25 | 2022-12-21 | Topix Pharmaceuticals, Inc. | METHODS, COMPOSITIONS, FILMS FOR THERAPEUTIC SKIN TREATMENTS |
CN110257140B (zh) * | 2019-06-17 | 2022-02-15 | 厦门路辉科技有限公司 | 一种光学高效芯取磨边液 |
WO2021021588A1 (en) * | 2019-07-26 | 2021-02-04 | Photokinetix Holdings Inc. | Intravaginal devices, compositions and methods to treat atrophic vaginitis |
CN110652484A (zh) * | 2019-11-04 | 2020-01-07 | 武汉赛锐希斯科技有限公司 | 一种针对银屑病肤质日常维护的洗发水配方 |
CN110833514B (zh) * | 2019-12-10 | 2023-05-09 | 广州赛莱拉干细胞科技股份有限公司 | 多肽冻干粉及其在制备抗衰老的化妆品中的应用 |
BR112022013144A2 (pt) * | 2020-01-21 | 2022-09-06 | Asc Regenity Ltd | Formulação cosmética para administração tópica compreendendo peptídeos que melhoram o aspecto e a regeneração da pele |
US12077780B2 (en) * | 2020-02-14 | 2024-09-03 | Allergan Sales, Llc | Conditioned medium from cells cultured under hypoxic conditions and uses thereof |
CN114007578A (zh) * | 2020-02-28 | 2022-02-01 | C·扎维拉 | 毛发增长及头皮制剂 |
US11590073B2 (en) | 2020-06-09 | 2023-02-28 | The Procter & Gamble Company | Methods and compositions for reducing the feeling of vaginal dryness |
CN111939458A (zh) * | 2020-08-25 | 2020-11-17 | 四川大学 | 一种具有超薄柔性背衬层的微针贴片及其制备方法 |
FR3117014B1 (fr) * | 2020-12-07 | 2024-01-12 | Oreal | Compositions de soin de la peau incluant l’acide azélaïque et procédés de fabrication d’une composition de soin de la peau |
US11464727B2 (en) * | 2020-09-29 | 2022-10-11 | Serendipity Technologies Llc | Reduced-cost cosmetic formulations that reduce visible signs of ageing |
WO2022140467A1 (en) * | 2020-12-21 | 2022-06-30 | Samson Pharma, Llc | Topical compositions and methods of treating skin diseases and conditions with such compositions |
US20220218584A1 (en) * | 2021-01-13 | 2022-07-14 | Allergan Sales, Llc | Topical composition and method of use |
WO2022157587A1 (en) * | 2021-01-23 | 2022-07-28 | Cellix Bio Private Limited | A composition comprising lidocaine, l-carnosine and dexpanthenol |
CN114469766A (zh) * | 2021-02-02 | 2022-05-13 | 江苏巴帝恩生物科技有限公司 | 一种含葡萄糖电解质的保湿及改善肌肤屏障的化妆品组成物 |
KR102259668B1 (ko) * | 2021-03-31 | 2021-06-01 | 신승연 | 프로테오글리칸-함유 크림 화장료 조성물 및 그의 제조방법 |
CN113376269A (zh) * | 2021-05-14 | 2021-09-10 | 广东药科大学 | 一种十一烯酰基苯丙氨酸的含量测定方法 |
US20220387284A1 (en) * | 2021-05-25 | 2022-12-08 | Allergan Sales, Llc | Topical composition and method of use |
CN113368004B (zh) * | 2021-06-15 | 2022-07-29 | 郑州三铠化妆品有限公司 | 一种具有抗衰修复功效的多肽组合物及其制备方法与应用 |
CN113440435B (zh) * | 2021-07-07 | 2022-08-09 | 珀莱雅化妆品股份有限公司 | 一种皮肤抗衰老组合物的制备方法 |
TWI818301B (zh) * | 2021-08-20 | 2023-10-11 | 富比積生物科技股份有限公司 | 寡肽於治療牙齦發炎和牙齦萎縮及修復口腔黏膜之用途 |
US20230129935A1 (en) * | 2021-10-22 | 2023-04-27 | Vaginal Biome Science, Inc. | System, product and method for maintaining the vaginal microbiome |
US20230130124A1 (en) * | 2021-10-25 | 2023-04-27 | Cosmed Pharmaceutical Co., Ltd. | Cosmetic microneedle |
CN114392393A (zh) * | 2021-12-17 | 2022-04-26 | 重庆米茜尔医疗美容门诊部有限公司 | 一种用于皮肤自我修复的皮下注射组合物及其使用方法 |
CN113956244B (zh) * | 2021-12-21 | 2022-03-29 | 浙江湃肽生物有限公司深圳分公司 | 一种用于皮肤复新的肌肽衍生物及其用途 |
US20230201105A1 (en) * | 2021-12-23 | 2023-06-29 | Guangen Xiang | Lip Gloss Formulation |
CN114369904A (zh) * | 2021-12-24 | 2022-04-19 | 浙江鹿达科技有限公司 | 一种抗菌无纺布卫生材料及其制备工艺 |
KR20230099481A (ko) * | 2021-12-27 | 2023-07-04 | (주)케어젠 | 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
KR20230099483A (ko) * | 2021-12-27 | 2023-07-04 | (주)케어젠 | 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
KR20230099480A (ko) * | 2021-12-27 | 2023-07-04 | (주)케어젠 | 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
KR20230099482A (ko) * | 2021-12-27 | 2023-07-04 | (주)케어젠 | 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
CN114452270B (zh) * | 2022-01-19 | 2022-09-27 | 广东省第二中医院(广东省中医药工程技术研究院) | 一种用于治疗骨关节炎的微针贴及其制备方法 |
CN114344217B (zh) * | 2022-01-24 | 2024-07-09 | 深圳市琉璃光生物科技有限公司 | 一种膏状抗氧化护肤品及其生产工艺 |
CN115024997B (zh) * | 2022-05-24 | 2023-11-17 | 彭氏(惠州)实业发展有限公司 | 具有抗皮肤衰老功效的化妆品组合物 |
CN115161274A (zh) * | 2022-06-08 | 2022-10-11 | 菲尔生物工程技术有限公司 | 一种脂肪干细胞提取物的抗皱精华液及其制备方法 |
CN115261419B (zh) * | 2022-07-23 | 2023-07-21 | 广州市博之越精细化工有限公司 | 一种γ-聚谷氨酸钠溶液的制备方法 |
CN115607467B (zh) * | 2022-09-27 | 2023-05-30 | 谢志辉生物医药研究院(广州)有限公司 | 一种含有壬二酸的低刺激性与美白、控油组合物 |
WO2024097166A1 (en) | 2022-11-02 | 2024-05-10 | Nutrition & Biosciences USA 4, Inc. | Compositions comprising xanthan gum and crystalline alpha-1,3-glucan |
KR20240072372A (ko) * | 2022-11-15 | 2024-05-24 | 웰펩 주식회사 | 가려움 유발 사이토카인 제어 효과가 우수한 펩티도미메틱 및 이를 포함하는 화장료 조성물 |
KR20240086708A (ko) * | 2022-11-18 | 2024-06-19 | (주)케어젠 | 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
KR20240086709A (ko) * | 2022-11-18 | 2024-06-19 | (주)케어젠 | 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도 |
KR102620622B1 (ko) * | 2023-09-08 | 2024-01-04 | 주식회사 제이포셀 | 보관 안정성이 향상된 egf를 함유하는 화장료 조성물 |
CN117731544A (zh) * | 2023-12-19 | 2024-03-22 | 广州集妍化妆品科技有限公司 | 一种含杏仁酸的具有靶向透皮递送功能的淡斑淡印美白增效组合物、其制备方法及其应用 |
CN117838563A (zh) * | 2024-01-09 | 2024-04-09 | 杭州悦萱堂化妆品有限公司 | 一种抗糖复合物及抗糖化妆剂组合物及制备方法 |
CN117982629B (zh) * | 2024-02-19 | 2024-07-19 | 北京盛美诺生物技术有限公司 | 一种iii型小分子胶原蛋白肽在改善面部肤质中的应用 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2668365B1 (fr) * | 1990-10-25 | 1994-12-23 | Sederma Sa | Utilisation en cosmetique des n-acetylpeptides dotes d'une activite biologique. |
DE69225631T2 (de) * | 1991-02-19 | 1998-12-17 | Cci Corp., Gifu | Acylaminosäure-Verbindungen und Verfahren zu ihrer Herstellung |
FR2701948B1 (fr) | 1993-02-22 | 1996-07-26 | Exsymol Sa | Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires. |
FR2711990B1 (fr) | 1993-11-05 | 1995-12-08 | Exsymol Sa | Produit pseudodipeptide possédant un groupement imidazole, et applications thérapeutiques, cosmétologiques et agroalimentaires. |
EP0920445B1 (fr) | 1996-08-23 | 2003-01-02 | Sederma S.A. | Peptides synthetiques et leur utilisation dans les compositions cosmetiques ou dermopharmaceutiques |
FR2756565B1 (fr) | 1996-12-04 | 1998-12-31 | Oreal | Nouveaux derives d'histidine et leur utilisation en cosmetique ou en pharmacie |
FR2783169B1 (fr) | 1998-09-15 | 2001-11-02 | Sederma Sa | Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution) |
FR2791684B1 (fr) | 1999-03-30 | 2001-05-11 | Sederma Sa | Composition cosmetiques ou dermopharmaceutiques contenant le tripeptide n-n-biotinyl-gly-his-lys pour prevenir, reduire ou supprimer la chute des cheveux ainsi que pour favoriser leur repousse |
FR2802413B1 (fr) | 1999-12-17 | 2003-10-31 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-palmytoyl-gly-hys-lys, pour eliminer, reduire ou prevenir l'apparition de rides quelles qu'en soient la localisation et la cause |
AUPQ515000A0 (en) * | 2000-01-19 | 2000-02-10 | Grigg, Geoffrey Walter | Treatment of uv induced immunosuppression |
FR2805744B1 (fr) | 2000-03-03 | 2006-08-25 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques contenant le dipeptide val-trp pour faciliter le drainage lymphatique et diminuer la masse adipeuse |
FR2810323B1 (fr) | 2000-06-16 | 2002-09-06 | Shiseido Int France | Utilisation cosmetique d'un lipopeptide |
EP1455744A2 (de) * | 2001-10-13 | 2004-09-15 | Beiersdorf AG | Kosmetische und/oder dermatologische wirkstoffkombination |
EP1551399A4 (en) | 2002-09-30 | 2011-01-05 | Mark A Babizhayev | METHOD FOR THE TOPICAL TREATMENT OF EYE DISEASES AND COMPOSITION AND DEVICE FOR THIS TREATMENT |
WO2004064866A1 (ja) | 2003-01-20 | 2004-08-05 | Innovative Vision Products, Inc. | カルノシナーゼ阻害剤とl−カルノシン類との併用および組成物 |
US7863417B2 (en) | 2003-05-08 | 2011-01-04 | Dsm Ip Assets B.V. | Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
FR2854897B1 (fr) | 2003-05-12 | 2007-05-04 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane. |
AU2003296248A1 (en) * | 2003-11-17 | 2005-06-08 | Sederma | Compositions containing mixtures of tetrapeptides and tripeptides |
ES2261036B1 (es) * | 2004-10-05 | 2007-12-16 | Lipotec, S.A. | Peptidos sinteticos que disminuyen o eliminan las bolsas formadas bajo el contorno inferior de los ojos y su uso en composiciones cosmeticas o dermofarmaceuticas. |
US7776915B2 (en) * | 2005-03-24 | 2010-08-17 | Tracie Martyn International, Llc | Topical formulations and methods of use |
US20070020220A1 (en) * | 2005-04-27 | 2007-01-25 | Procter & Gamble | Personal care compositions |
AR058140A1 (es) * | 2005-10-24 | 2008-01-23 | Wyeth Corp | Metodo de produccion proteica utilizando compuestos anti-senescencia |
CN1810828A (zh) * | 2006-03-03 | 2006-08-02 | 华东师范大学 | 一种脂肪酸-肌肽复合物及其制备方法 |
US20070237735A1 (en) * | 2006-03-31 | 2007-10-11 | Laboratoires Dermo-Cosmetik Inc. | Anti-aging composition, kit and method of use |
US8586541B2 (en) | 2006-06-01 | 2013-11-19 | Therapeutic Peptides, Inc. | Polymeric biosurfactants |
PT2409988E (pt) * | 2006-06-13 | 2015-10-12 | Helix Biomedix Inc | Fragmentos peptídicos para induzir síntese de proteínas da matriz extracelular |
EP2065029B1 (en) * | 2007-11-30 | 2013-04-17 | Evonik Goldschmidt GmbH | Personal care and cosmetic composition containing tetrapeptides with the motifs GX1X2G, PX1X2P, or PX1X2K |
ES2342754B1 (es) * | 2008-10-03 | 2011-05-11 | Lipotec, S.A. | Peptidos utiles en el tratamiento y/o cuidado de la piel, mucosas, cuero cabelludo y/o cabello y su uso en composiciones cosmeticas o farmaceuticas. |
FR2941231B1 (fr) | 2009-01-16 | 2016-04-01 | Sederma Sa | Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques. |
CA2748375C (en) | 2009-01-16 | 2017-08-01 | Neocutis Sa | Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions |
FR2945939B1 (fr) | 2009-05-26 | 2011-07-15 | Sederma Sa | Utilisation cosmetique du dipeptide tyr-arg pour lutter contre le relachement cutane. |
EP2437602A4 (en) | 2009-06-05 | 2014-02-19 | Aciex Therapeutics Inc | OPHTHALMIC FORMULATIONS, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR THEIR USE |
FR2946251B1 (fr) * | 2009-06-08 | 2011-05-20 | Oreal | Composition cosmetique comprenant un derive d'acide salicylique et de la carnosine. |
WO2011109469A1 (en) | 2010-03-03 | 2011-09-09 | Neocutis Sa | Compositions and methods for treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds |
FR2975904B1 (fr) * | 2011-06-01 | 2013-08-23 | Sederma Sa | Nouvelle utilisation topique, cosmetique ou dermopharmaceutique, d'un melange comprenant un tripeptide du type ghk et un tetrapeptide du type gqpr |
MX360649B (es) | 2013-03-13 | 2018-11-12 | Anteis Sa | Péptidos para el rejuvenecimiento de la piel y métodos de uso de los mismos. |
-
2014
- 2014-02-26 MX MX2015011498A patent/MX360649B/es active IP Right Grant
- 2014-02-26 RU RU2015131719A patent/RU2666533C2/ru active
- 2014-02-26 CN CN201480012627.7A patent/CN105189531B/zh active Active
- 2014-02-26 AU AU2014229557A patent/AU2014229557B2/en active Active
- 2014-02-26 JP JP2015562393A patent/JP6326601B2/ja active Active
- 2014-02-26 EP EP14747114.8A patent/EP2970382B1/en active Active
- 2014-02-26 WO PCT/IB2014/001119 patent/WO2014140890A2/en active Application Filing
- 2014-02-26 CA CA2902938A patent/CA2902938C/en active Active
- 2014-02-26 KR KR1020157025086A patent/KR102276326B1/ko active IP Right Grant
- 2014-02-26 SG SG11201506069RA patent/SG11201506069RA/en unknown
- 2014-03-04 TW TW103107248A patent/TWI652066B/zh active
- 2014-03-10 US US14/202,418 patent/US9375398B2/en active Active
- 2014-03-12 AR ARP140100889A patent/AR095276A1/es unknown
-
2016
- 2016-01-12 HK HK16100287.4A patent/HK1212363A1/xx unknown
- 2016-05-25 US US15/164,686 patent/US10543195B2/en active Active
-
2019
- 2019-12-10 US US16/709,838 patent/US11331305B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20200093799A1 (en) | 2020-03-26 |
HK1212363A1 (en) | 2016-06-10 |
CA2902938A1 (en) | 2014-09-18 |
US10543195B2 (en) | 2020-01-28 |
RU2666533C2 (ru) | 2018-09-11 |
CN105189531A (zh) | 2015-12-23 |
US9375398B2 (en) | 2016-06-28 |
TW201521758A (zh) | 2015-06-16 |
WO2014140890A3 (en) | 2015-04-09 |
KR102276326B1 (ko) | 2021-07-13 |
AU2014229557B2 (en) | 2017-12-07 |
US20140309173A1 (en) | 2014-10-16 |
RU2015131719A (ru) | 2017-04-20 |
MX360649B (es) | 2018-11-12 |
JP6326601B2 (ja) | 2018-05-23 |
US11331305B2 (en) | 2022-05-17 |
SG11201506069RA (en) | 2015-09-29 |
EP2970382A2 (en) | 2016-01-20 |
EP2970382B1 (en) | 2019-09-25 |
AU2014229557A1 (en) | 2015-10-22 |
MX2015011498A (es) | 2016-05-31 |
JP2016516023A (ja) | 2016-06-02 |
WO2014140890A2 (en) | 2014-09-18 |
CN105189531B (zh) | 2020-02-21 |
CA2902938C (en) | 2021-06-01 |
TWI652066B (zh) | 2019-03-01 |
KR20150126621A (ko) | 2015-11-12 |
US20160271109A1 (en) | 2016-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR095276A1 (es) | Péptidos para el rejuvenecimiento de la piel y métodos para utilizarlos | |
BR112017012474A2 (pt) | composto peptídico, composição cosmética ou dermofarmacêutica, uso de pelo menos um composto peptídico, e, método para aumentar a atividade na síntese de macromoléculas do ecm da pele de um composto peptídico. | |
Zhang et al. | Cosmeceuticals and peptides | |
CN108495646B (zh) | 用于治疗和/或护理皮肤、毛发、指甲和/或粘膜的化合物 | |
NZ630469A (en) | Methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases | |
CO6640331A2 (es) | Tratamiento anti-envejecimiento de la piel | |
US20190153030A1 (en) | Peptide, composition comprising said peptide and uses thereof, in particular cosmetic uses | |
EP2528934A4 (en) | AROMATIC-CATIONIC PEPTIDES AND USES THEREOF | |
AR100134A1 (es) | Métodos y composiciones de administración tópica para el cuidado de la piel | |
CO2018002328A2 (es) | Formulaciones que comprenden variantes de péptido natriurético de tipo c (cnp) | |
JP2016516023A5 (es) | ||
AR083885A1 (es) | Analogos de dipeptidos para el tratamiento de afecciones asociadas con la formacion de fibrillas amiloides | |
PE20130648A1 (es) | Tratamiento del sindrome de sanfilippo tipo b | |
RU2017123388A (ru) | Пептиды и их применение в уходе за кожей | |
AR082246A1 (es) | Composicion farmaceutica de anticuerpo a receptor cannabinoide humano | |
WO2015081306A3 (en) | Peptide tyrosinase activators | |
MX2015006333A (es) | Composiciones farmaceuticas y metodos terapeuticos de uso que comprenden agonistas selectivos del receptor de melanocortina. | |
WO2015183995A3 (en) | Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof | |
EA201500061A1 (ru) | Фармацевтическая композиция для терапии легочной формы высотной болезни, вызванной кислородным голоданием и пониженным атмосферным давлением | |
AR060251A1 (es) | Peptidos sinteticos utiles en el tratamiento de la piel y su uso en composiciones cosmeticas o dermofarmaceuticas | |
NZ628660A (en) | Bifunctional peptide | |
AR097216A1 (es) | Composición para el tratamiento contra el envejecimiento de la piel | |
BR112018070929A2 (pt) | peptídeos bioativos peguilados e seu uso | |
Linder | The science behind peptides | |
CN116615178A (zh) | 美容四肽、组合物及用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |